[144] Verastem, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Verastem, Inc. (VSTM) reporting a proposed sale of 31,790 common shares through Raymond James & Associates on 09/17/2025 on NASDAQ with an aggregate market value of $310,429.00. The filing lists total shares outstanding of 63,043,373. The securities were acquired as compensation (RSUs) in multiple grants between 03/11/2013 and 12/31/2021, with individual grant sizes shown (for example, 9,532 shares on 12/31/2020 and 9,216 on 08/11/2021). The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: A non-material planned sale of 31,790 RSU-derived shares is reported; no recent sales and no undisclosed material information claimed.

The filing documents a proposed sale of 31,790 common shares valued at $310,429 to be executed through Raymond James on 09/17/2025. The shares originate from RSU compensation grants spanning 2013–2021. The filing states total shares outstanding of 63,043,373, implying the proposed sale represents a very small fraction of outstanding shares. No securities were reported sold in the past three months. The filer’s attestation asserts no undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice for RSU-derived shares; procedural disclosure with no flagged governance issues in the filing.

The notice follows Rule 144 requirements, identifying the broker, number of shares, market value, acquisition dates and nature (RSU compensation), and outstanding share count. It includes the mandatory representation regarding material nonpublic information and indicates no recent sales to aggregate. The content shows standard disclosure mechanics rather than governance or compliance exceptions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	31790	310429.00	63043373	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2013	Acquired as Compensation - RSUs	Issuer			1262	03/11/2013	Compensation
Common	08/01/2013	Acquired as Compensation - RSUs	Issuer			643	08/01/2013	Compensation
Common	02/03/2014	Acquired as Compensation - RSUs	Issuer			648	02/03/2014	Compensation
Common	08/01/2014	Acquired as Compensation - RSUs	Issuer			659	08/01/2014	Compensation
Common	02/02/2015	Acquired as Compensation - RSUs	Issuer			664	02/02/2015	Compensation
Common	08/03/2015	Acquired as Compensation - RSUs	Issuer			661	08/03/2015	Compensation
Common	02/01/2016	Acquired as Compensation - RSUs	Issuer			1190	02/01/2016	Compensation
Common	06/28/2019	Acquired as Compensation - RSUs	Issuer			278	06/28/2019	Compensation
Common	12/31/2019	Acquired as Compensation - RSUs	Issuer			278	12/31/2019	Compensation
Common	06/30/2020	Acquired as Compensation - RSUs	Issuer			278	06/30/2020	Compensation
Common	12/31/2020	Acquired as Compensation - RSUs	Issuer			9532	12/31/2020	Compensation
Common	12/31/2020	Acquired as Compensation - RSUs	Issuer			278	12/31/2020	Compensation
Common	08/11/2021	Acquired as Compensation - RSUs	Issuer			9216	08/11/2021	Compensation
Common	12/18/2021	Acquired as Compensation - RSUs	Issuer			1914	12/18/2021	Compensation
Common	12/31/2021	Acquired as Compensation - RSUs	Issuer			4289	12/31/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Verastem (VSTM) report?

The Form 144 reports a proposed sale of 31,790 common shares valued at $310,429.00 to be sold on 09/17/2025 via Raymond James on NASDAQ.

How many Verastem shares are outstanding according to this filing?

The filing lists 63,043,373 shares outstanding.

What is the origin of the shares being sold in the VSTM Form 144?

All listed shares were acquired as compensation (RSUs) in grants dated between 03/11/2013 and 12/31/2021.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker named in the Form 144 for VSTM?

The broker named is Raymond James & Associates at the address provided in the filing.